Metabolic syndrome treatment: focusing on acarbose
Aim. To compare the effectiveness of alpha-glucosidase inhibitor acarbose (150 or 300 mg/d) and non-pharmaceutical lifestyle modification in controlling arterial hypertension (AH), carbohydrate and lipid metabolism, and body weight (BW) among patients with impaired glucose tolerance (IGT) and AH.Mat...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
«SILICEA-POLIGRAF» LLC
2008-04-01
|
| Seri Bilgileri: | Кардиоваскулярная терапия и профилактика |
| Konular: | |
| Online Erişim: | https://cardiovascular.elpub.ru/jour/article/view/1331 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|